Table Olives — Body Handbook

კვება · §358

Table Olives

A handful of olives at 4pm is a real upgrade on a packet of crisps — but only if you bought the right jar. The curing style decides almost everything: how much of the cholesterol-protecting compound called hydroxytyrosol survives, how much sodium comes with it, whether you're holding a slow-fermented Kalamata or a lye-stripped California black. The monounsaturated fat is the same in all of them. The salt is the catch. The polyphenols depend on what you grabbed.

Do · Daily Evidence Mixed თავი კვება

A modest food made modestly useful. The win: a slow drip of cholesterol-protecting polyphenols, a clean source of the same monounsaturated fat as olive oil, a snack that drops cleanly into a Mediterranean-style day at near-zero cost or effort. The catch: salt. A Spanish-style or dry-cured jar can spend a quarter of your daily sodium budget in one handful; a standard California-style black olive has had most of its polyphenols stripped on the way to the can. Pick the cure right and a small bowl earns its place; pick it wrong and you've swapped sugar and crisps for salt and disappointment.

What you're eating is the whole fruit of the olive tree, not its oil. The fat — about 11 grams per 100 grams of cured olive — is mostly oleic acid, the same monounsaturated fat that gives extra-virgin olive oil its cardiovascular reputation López-Miranda et al. 2010. The fruit also carries a small family of plant compounds called polyphenols — chiefly hydroxytyrosol — and roughly three grams of fibre per 100 grams. None of the fibre survives the press into oil, and a meaningful share of the polyphenols don't either, which is what makes a whole olive a slightly different food from a teaspoon of EVOO EFSA 2011.

There's a catch the supermarket doesn't tell you. Olives are bitter on the tree — inedible — so every jar has been debittered first. Slow brine fermentation (Kalamata, Castelvetrano, traditional brine-cured Manzanilla) keeps most of the hydroxytyrosol intact. Lye debittering followed by air oxidation — the bog-standard canned California black — strips most of it out Romero et al. 2004 Charoenprasert and Mitchell 2012. One jar of olives can carry ten times more polyphenol than the next jar over.

Every curing process also leans on salt. There is no version that doesn't. The differences are large: a 100-gram serving of California ripe canned olives is around 735 milligrams of sodium; the same serving of Spanish-style green can be 1,400 to 1,600 milligrams; dry-cured Moroccan can sit above 2,400 USDA Charoenprasert and Mitchell 2012. The polyphenols and the salt come bundled, and the bundle isn't the same in every jar.

What we know it does

Direct trials on whole table olives are thin on the ground. Almost all of the cardiovascular evidence sits one step over, on olive oil — and the move from oil to olives is largely a question of polyphenol dose. The European Food Safety Authority concluded in 2011 that 5 milligrams a day of hydroxytyrosol and its derivatives — about what 20 grams of high-polyphenol olive oil delivers — measurably protects LDL cholesterol from being chemically modified inside your blood vessels, which is the first step on the road to an arterial plaque EFSA 2011.

That polyphenol dose is reachable from naturally fermented olives, not from the standard supermarket California black. A small bowl of Kalamatas delivers a meaningful fraction of the 5 mg threshold; the same bowl of canned blacks gives you a tenth of that or less Romero et al. 2004. The compound is the same; the dose is not.

Olives also rode along inside PREDIMED, the Spanish primary-prevention trial that randomised roughly 7,400 adults at cardiovascular risk to a Mediterranean diet with extra-virgin olive oil, the same diet with nuts, or a low-fat control. Over almost five years, the olive-oil arm had about a third fewer heart attacks, strokes, and cardiovascular deaths than the controls — a large effect for a real-world dietary pattern in which a small daily portion of table olives was an unremarkable part of the day Estruch et al. 2018. The trial does not let anyone pin that benefit on olives specifically; it tells you they sit comfortably inside the pattern that produces it. Long-running cohort data on Mediterranean adherence point the same direction Trichopoulou et al. 2003 Sofi et al. 2010 Schwingshackl and Hoffmann 2014.

Inside the body, the mechanism behind those numbers is plausible at the artery wall: olive polyphenols help your blood vessels relax appropriately under stress and damp the low-grade inflammation that gets atherosclerosis going Storniolo et al. 2014. Modest reductions in blood pressure show up in trials of concentrated olive-leaf extract (a different product with much higher polyphenol density) Lockyer et al. 2017 Susalit et al. 2011. A whole-olive snack is a much weaker version of those interventions; the polyphenol dose is lower and the sodium dose is much higher. The same machinery is in play; the size of the effect isn't.

The same machinery — slower oxidative wear on tissues, calmer blood vessels — is the slow engine behind the well-documented "Mediterranean look" people in their fifties on this kind of diet sometimes carry into their sixties. It's the slowest-acting of the gains, indistinguishable from the broader dietary pattern, and a real reason olives belong on the shopping list rather than the special-occasion list.

Satiety, the fourth claim worth naming, is the weakest of the four. There's no good controlled trial on whole table olives. The Mediterranean arm of a two-year weight-loss trial that included olives as a regular snack option matched or outperformed a low-fat diet at the same calories Shai et al. 2008, but the design can't isolate olives from the rest of the menu. Fibre plus fat plus a pit to work around plausibly slows you down at the bowl. Don't expect to feel it.

How much, which jar

Aim for five to ten olives a day, naturally cured — Kalamata, Castelvetrano, or a real-brine Manzanilla. That's roughly 15 to 40 grams of fruit. Inside that range the polyphenols do real work and the sodium stays around 150–600 milligrams, which is manageable inside a daily salt budget.

The right cadence is small and often, with a meal or in the late afternoon. A monthly olive binge doesn't reproduce the steady polyphenol drip and dumps the salt all at once. Cost is trivial — a good imported jar runs four to ten dollars and lasts a couple of weeks once opened. The only effort is reading the label the first few times.

When to scale back

If your blood pressure is high, your kidneys are working overtime, or you already know you're salt-sensitive, scale back the curing style before you scale back the amount. A daily 30-gram serving of Spanish-style olives hands you about 450 milligrams of sodium — roughly a quarter of the World Health Organization's daily target WHO 2012. The same weight of Castelvetrano or California ripe is closer to half that. Or rinse before serving. Or eat the same olives less often. Olives aren't off the menu — it's a curing-style problem, not an olive problem He et al. 2013.

Three myths worth dropping

Olives are not just olive oil in solid form. The fat is the same; the polyphenol fingerprint isn't. Curing — especially the lye step — strips a lot of the hydroxytyrosol that earned extra-virgin olive oil its European LDL-protection claim, and EVOO is pressed precisely to keep it. A bowl of olives is not a tablespoon of EVOO EFSA 2011 Romero et al. 2004.

Sea-salt-cured is not gentler than table-salt-cured. The thing that raises blood pressure is sodium, and its geological history does not matter. Hand-harvested dry-salt-cured Moroccan olives are among the saltiest items in the entire olive aisle Charoenprasert and Mitchell 2012.

Olives are not a superfood. The hydroxytyrosol mechanism is real, the dose-response is real, the studies are real. The honest summary is that the doses producing measurable benefit on LDL oxidation sit at the upper edge of plausible whole-olive snacking, and that the sodium that comes with the polyphenol can wipe the cardiovascular gain in salt-sensitive readers. Real, modest, real catch EFSA 2011 Strazzullo et al. 2009.

Three adjacent topics pair with this one. Extra-virgin olive oil is where most of the cardiovascular trials actually live and where the polyphenol dose is more reliably high. The Mediterranean dietary pattern is the larger context table olives sit inside — the trials that produce the headline mortality numbers run on the whole pattern, not on its salty garnish. And sodium reduction as its own lever decides, for a meaningful share of readers, whether olives net positive or negative on the cardiovascular ledger.

Substance and claimed effects

Table olives are the whole drupe fruit of Olea europaea, debittered through one of several curing processes and eaten as a snack, antipasto, or ingredient. They are distinct from olive oil in matrix, polyphenol fingerprint, and sodium load: the whole fruit retains fibre and a residual polyphenol fraction (mostly hydroxytyrosol, tyrosol, verbascoside, and small amounts of intact oleuropein after debittering), but every curing style introduces sodium chloride in non-trivial quantities Romero et al. 2004 Charoenprasert and Mitchell 2012. This entry covers the consequences flagged in the brief — effects on LDL cholesterol and LDL oxidation, endothelial function, antioxidant markers, satiety — alongside the sodium trade-off that depends on curing style. It does not cover olive oil (the bulk of the cardiovascular literature), olive leaf extract, or the Mediterranean dietary pattern as a whole; those are adjacent entries.

Evidence by addressing question

mechanism

A 100 g serving of cured table olives carries roughly 115–145 kcal, 10–15 g fat (≈74% monounsaturated, dominated by oleic acid), ≈3 g fibre, and a residual polyphenol fraction that ranges from ~30 mg/kg in lye-treated Spanish or California-style fruit up to ~700–900 mg/kg in naturally fermented Greek-style Kalamata or natural-brine Manzanilla USDA FoodData Central Romero et al. 2004 Charoenprasert and Mitchell 2012. The dominant phenolics after curing are hydroxytyrosol (the same molecule that earned EVOO its EFSA-authorised LDL-protection claim) and tyrosol; oleuropein, the bitter glucoside intact in the fresh fruit, is largely hydrolysed during debittering, with the hydrolysis product hydroxytyrosol partly leaching into the brine EFSA 2011 Conte et al. 2020.

The candidate mechanisms for cardiovascular benefit are: (a) oleic acid displaces saturated fat in the diet, modestly lowering LDL-C in the standard isocaloric substitution model López-Miranda et al. 2010; (b) hydroxytyrosol and its conjugates inhibit LDL oxidation in vitro and in human feeding trials, reducing the atherogenicity of circulating LDL particles EFSA 2011 Covas et al. 2006; (c) polyphenol-driven NO release and endothelin-1 suppression improve endothelium-dependent vasodilation Storniolo et al. 2014; (d) fibre plus fat slow gastric emptying, supporting between-meal satiety. Mechanism (a) is settled; (b) is well-substantiated for olive oil and plausibly transfers to the whole fruit at sufficient phenolic intake; (c) is mechanistic with limited human-endpoint data; (d) is plausible but has thin direct evidence in the whole-olive matrix.

The sodium side is mechanistically simple. Pressor effect of sodium chloride is dose-responsive in salt-sensitive individuals (≈30–50% of adults depending on baseline BP) He et al. 2013; per-meal sodium loads of 200–400 mg from a single snack are not trivial in the context of a 1500–2000 mg WHO target WHO 2012.

evidence

Direct RCT evidence on whole table olives is sparse; the bulk of the cardiovascular case is extrapolated from olive oil and from Mediterranean-diet trials in which table olives are a regular component. The strongest single trial in the oil-polyphenol class is the EUROLIVE crossover (n=200 healthy European men), in which 25 mL/day of high-phenolic olive oil for three weeks raised HDL-C by a small but significant amount and reduced oxidised LDL relative to low-phenolic oil Covas et al. 2006. The EFSA Panel concluded in 2011 that a daily intake of 5 mg of hydroxytyrosol and its derivatives — the amount supplied by ~20 g of typical EVOO — produces a measurable reduction in LDL oxidation EFSA 2011. A 100 g portion of naturally fermented table olives can supply 30–100 mg of total phenolics, of which a meaningful fraction is hydroxytyrosol; lye-treated olives can fall an order of magnitude below this Romero et al. 2004 Charoenprasert and Mitchell 2012.

The PREDIMED primary-prevention trial randomised ~7,400 high-CV-risk adults to a Mediterranean diet supplemented with EVOO or nuts versus a low-fat control; over a median 4.8 years, the EVOO arm showed a ~30% reduction in major adverse cardiovascular events (HR 0.69, 95% CI 0.53–0.91) Estruch et al. 2018. Table olives were part of the dietary pattern but not isolated as an active arm. Cohort-level evidence — the Greek arm of EPIC Trichopoulou et al. 2003, meta-analyses pooling Mediterranean-adherence scores Sofi et al. 2010, and the MUFA/olive-oil pooled cohort meta-analysis from Schwingshackl and Hoffmann Schwingshackl and Hoffmann 2014 — supports a mortality and CVD-event reduction with higher olive consumption (oil-dominant), but cannot disentangle table-olive intake from the full pattern.

Endothelial function: extra-virgin olive oil polyphenols restore NO bioavailability and dampen endothelin-1 in cultured human endothelial cells challenged with high glucose and free fatty acids Storniolo et al. 2014; phenolic-rich olive leaf extract lowered systolic BP by ~3 mm Hg in a 6-week RCT in adults with normal-to-high BP Lockyer et al. 2017 and was non-inferior to low-dose captopril in stage-1 hypertensives in an 8-week head-to-head Susalit et al. 2011. These are leaf-extract and oil studies, not whole table olive — the polyphenol payload there is several-fold higher than from a realistic olive snack. Marrugat et al. showed that higher-phenolic olive oil reduced ex-vivo LDL oxidation in normolipidaemic men over a three-week feeding period Marrugat et al. 2004.

Satiety: thin literature on whole table olives specifically. The Mediterranean-diet arm of the Shai et al. 2-year weight-loss RCT (n=322) achieved equal or better weight loss than the low-fat arm and included olives as a daily snack option Shai et al. 2008; this is consistent with — but does not isolate — a satiety contribution from olives.

Sodium and CVD: this is the counter-evidence. He et al.'s Cochrane meta-analysis of long-term salt-reduction trials showed a sodium-intake reduction of ~4.4 g/day lowered SBP by 4.2 mm Hg in normotensives and 5.4 mm Hg in hypertensives He et al. 2013; Strazzullo et al.'s prospective-cohort meta-analysis (n=177,025) found a 23% higher stroke risk and 14% higher CVD risk with higher habitual sodium Strazzullo et al. 2009; Mozaffarian et al. modelled ≈1.65 million annual CV deaths globally attributable to sodium intake above 2 g/day Mozaffarian et al. 2014. The PURE/Mente analyses muddy this picture in the very-low-sodium tail, suggesting a J-shape rather than monotonic dose-response — particularly contested below 3 g/day — and the field is not unified there Mente et al. 2016.

protocol

A reasonable daily intake of table olives, scaled to deliver a meaningful polyphenol load without overrunning sodium budget, is approximately 5–10 olives per day (≈15–40 g) of a naturally fermented, brine-cured variety. This delivers roughly 1.5–6 mg of total phenolics (a meaningful fraction of the EFSA 5 mg/day threshold when combined with cooking olive oil), 1–6 g of olive fat (predominantly oleic), and — critically — 150–600 mg of sodium depending on cultivar and curing house USDA FoodData Central Romero et al. 2004.

Curing-style sodium load, approximate per 100 g of drained fruit:

Dry-salt-cured (Moroccan oil-cured, "wrinkled black"): ~2,400–4,000 mg sodium
Spanish-style green (lye + lactic fermentation, e.g. Manzanilla, Gordal): ~1,400–1,600 mg sodium
Greek-style natural-brine (Kalamata, Conservolea): ~870–1,500 mg sodium
California-style "ripe" (lye + air oxidation, ferrous gluconate): ~735 mg sodium
Castelvetrano / water-cured Sicilian: ~620–800 mg sodium (lower brine concentration; shorter shelf life)

For polyphenol content, the rank order roughly inverts: naturally fermented brine-cured ≫ Castelvetrano ≫ Spanish lye-treated ≫ California "ripe" (the lye step plus air oxidation strips most of the phenolic fraction) Romero et al. 2004 Charoenprasert and Mitchell 2012 Conte et al. 2020. The reader's practical heuristic: a Kalamata gives more polyphenol per milligram of sodium than a canned California black; a Castelvetrano gives the best polyphenol-to-sodium ratio overall but is harder to find shelf-stable.

Rinsing drained olives under tap water for 10–20 seconds before eating removes a modest fraction of surface sodium without measurably affecting polyphenol content, since most phenolics are pulp-bound; this is a soft hack rather than a rigorous protocol.

contraindications

Salt-sensitive hypertension is the clearest scope-out: a daily 30 g serving of Spanish-style olives can contribute ~450 mg sodium, ≈25% of WHO's 2 g/day target WHO 2012. The He et al. dose-response indicates a meaningful BP impact at that sodium delta in salt-sensitive individuals He et al. 2013. Heart failure, chronic kidney disease (especially stages 3–5), and uncontrolled hypertension all warrant either lower-sodium curing styles (Castelvetrano, California "ripe"), rinsing, or a tighter cap on serving size. Pregnancy is not a contraindication, but sodium guidance still applies.

misconceptions

Three common errors:

"Olives are basically olive oil." They share the oleic-acid backbone but the curing process — particularly lye treatment — strips most of the oleuropein-derived polyphenols that earn olive oil its protective signal. A 20 g serving of high-phenolic EVOO delivers the EFSA-claimed 5 mg of hydroxytyrosol; a 20 g serving of California black olives may deliver under 0.5 mg EFSA 2011 Romero et al. 2004.
"Sea-salt-cured is healthier than industrial." The cation that matters is sodium, not the geological origin of the salt crystal. Dry-salt-cured Moroccan olives carry some of the highest sodium loads in the category Charoenprasert and Mitchell 2012.
"Olives are a superfood." The hydroxytyrosol literature is real but the doses that produce measurable lipid-oxidation effects in trials are at the upper end of plausible whole-olive intake, and the sodium offset can wipe out the cardiovascular gain in salt-sensitive readers EFSA 2011 Strazzullo et al. 2009.

alternatives

For the polyphenol axis: extra-virgin olive oil delivers the same hydroxytyrosol family with no sodium cost and a far better polyphenol-per-calorie ratio. For the salty-savoury-snack-with-fat axis: unsalted nuts (almonds, walnuts) hit the MUFA and fibre targets with no sodium and stronger weight-loss / cardiovascular evidence in PREDIMED's nut arm Estruch et al. 2018. Table olives' niche is the combination of texture, satiety, and Mediterranean-meal compatibility rather than uniqueness in any single mechanism.

failure-modes

The most common reader failure is treating olives as a "free" health food and over-snacking. A 200 g jar of Kalamatas eaten across an evening contributes >1.7 g of sodium — roughly the entire WHO daily target — for an aesthetic reward whose polyphenol benefit caps out well below that intake. The second failure is selecting on the wrong axis: choosing pitted black "California-style" canned olives (low polyphenol, oxidised colour, ferrous gluconate as colour stabiliser) because they are convenient, then concluding olives "didn't do much" — they didn't, but a Kalamata or Castelvetrano would have.

practicalities

Cost is trivial — a 200–500 g jar of naturally fermented olives is $4–$10 at most supermarkets and lasts 2–3 weeks refrigerated. Effort is near-zero. The practical friction is selection: cheap olives are usually lye-treated and polyphenol-poor; the labels rarely declare polyphenol content. Read for "naturally cured" or "in brine" rather than "ripe" or "California-style"; Greek imports labelled Kalamata, Italian Castelvetrano (often refrigerated, not shelf-stable), and Spanish Manzanilla/Gordal in brine all fit. Rinse if sodium-conscious; pit-in is fine (and a soft satiety aid via slower eating pace).

history

Table olives are among the oldest preserved foods in the human diet — fermentation evidence in the Mediterranean basin dates to ~6,000 BCE. The two innovations that produced the modern landscape were the Spanish 19th-century lye-debittering process (which industrialised the green-olive category) and the Californian 20th-century air-oxidation black-olive process (which produced the uniform-black, low-polyphenol canned olive). Both processes traded polyphenol content for shelf stability and speed-to-market Conte et al. 2020.

stakes

The "stakes" axis is modest for this entry. Table olives are neither dominant in the Mediterranean diet's mortality signal nor culpable in obvious harms beyond the sodium load. The honest stakes story is one of substitution: a reader who replaces a daily packet of crisps with a small bowl of naturally cured olives swaps a saturated-fat / refined-carb / sodium hit for a MUFA / fibre / polyphenol / sodium hit — a real net improvement, on the order of small population-level CV benefit, not a transformative one Schwingshackl and Hoffmann 2014.

payoff

Payoff: modest, slow, hard to feel. Polyphenol-driven LDL-oxidation reductions are biochemical not subjective; the MUFA substitution shows up in lipid panels over months, not weeks; satiety effect is plausible but small. The real payoff is the substitution: better-quality snack within an already Mediterranean-flavoured eating pattern.

out-of-scope

Adjacent entries this one should eventually cross-link to: olive oil (the bulk of the cardiovascular evidence base), the Mediterranean dietary pattern, sodium reduction as a standalone intervention, and (lookmaxxing-adjacent) MUFA-rich snack alternatives like raw almonds.

Credibility range

Optimist case

Table olives are a vector for the same hydroxytyrosol-family polyphenols that earned olive oil the EFSA-substantiated LDL-protection claim EFSA 2011. The whole-fruit matrix adds fibre and slow-eating cadence the oil lacks, which plausibly improves the satiety profile and the substitution effect against ultra-processed snacks. Mediterranean-diet trials consistently associate table-olive intake with favourable cardiovascular outcomes Sofi et al. 2010 Estruch et al. 2018, and millennia of Mediterranean consumption argue against any meaningful safety signal at culinary doses. Sodium content varies enormously by curing style, so the salt-sensitive concern can be navigated by cultivar selection rather than blanket avoidance.

Skeptic case

Direct RCTs on whole table olives as a discrete intervention are essentially absent — the cardiovascular case is extrapolation from olive oil and from dietary-pattern trials in which olives are a passenger. The polyphenol payload that produces measurable LDL-oxidation benefit (5 mg/day hydroxytyrosol) is at the upper end of realistic whole-olive intake even with high-polyphenol cultivars, and the dominant supermarket varieties (lye-treated green, oxidised California black) deliver one to two orders of magnitude less polyphenol than the literature assumes Romero et al. 2004. Meanwhile, sodium intakes above 5 g/day reliably elevate BP and stroke risk; a habitual olive snacker on Spanish-style or dry-cured fruit can plausibly net negative on cardiovascular outcomes by trading a small polyphenol benefit for a real sodium burden Strazzullo et al. 2009 Mozaffarian et al. 2014.

Author's call

Table olives are a real-but-modest positive food choice that pivots on curing-style selection. The optimist case earns its hydroxytyrosol/MUFA mechanism credit in naturally fermented cultivars eaten at culinary doses (≈30 g/day); the skeptic case wins on supermarket-default California-style fruit and on heavy daily consumption of high-sodium varieties. Evidence is sparse for table olives in isolation, strong for the olive-oil parent literature, and the field's controversy is mild — mostly inherited from the contested-edges of the sodium-BP literature, not from olives themselves. Score the entry honestly: not a longevity headliner, real polyphenol and MUFA contribution, real sodium offset, low burden, and a useful nudge toward better snacking.

Stakeholders and incentives

Olive-growing regions and the IOC (International Olive Council) — promote table olives as a Mediterranean health food; commercial incentive to elide curing-style polyphenol differences.
Mediterranean-diet researchers — Spanish, Greek, and Italian academic groups; sincere science, occasional regional pride bleed-through.
Cardiology and hypertension guideline bodies (AHA, ESC, WHO) — push sodium reduction; can read olives as a sodium-vector and underweight the polyphenol axis.
Salt-skeptic camp (PURE-aligned researchers) — argue against aggressive sodium reduction below 3 g/day; relevant to interpreting the BP trade-off Mente et al. 2016.
Big-food private-label olive processors — favour high-volume lye-and-can processes (lower polyphenol, longer shelf life) over slow natural fermentation.

Population variability

Salt sensitivity: ~30% of normotensives, ~50% of hypertensives, and a higher fraction of older / Black / overweight adults respond to sodium load with measurable BP rises He et al. 2013. The sodium calculus tilts these readers toward Castelvetrano / California-style or against habitual heavy consumption.
Baseline LDL-C: the lipid-improvement signal from polyphenol-rich olive products is larger in those with elevated baseline LDL, milder in normolipidaemics Covas et al. 2006.
Dietary pattern: readers already on a Mediterranean-pattern diet gain less marginal benefit from adding olives; readers swapping refined-carb snacks gain more.
Region of supply: European-cured imports (Greek, Italian, Spanish) typically retain more polyphenols than American canned products; this is a real shelf-quality bifurcation, not a regional-pride trope Romero et al. 2004.

Knowledge gaps

No RCT has tested whole table olives as a discrete intervention with cardiovascular endpoints. Whole-olive lipid-panel trials at 50–100 g/day would close the largest gap.
Bioavailability of hydroxytyrosol from the whole-olive matrix (fibre-bound, fat-emulsified) versus from olive oil is under-characterised; absorption may differ.
Satiety effect of table olives specifically — independent of the Mediterranean meal context — is largely untested in controlled feeding trials.
The sodium net effect at realistic snacking doses (10–30 g/day) in mixed-cultivar consumption has not been modelled against the polyphenol benefit on cardiovascular endpoints; current calls are mechanism-based extrapolation.

Brief vs entry. The input description named LDL cholesterol, endothelial function, antioxidant markers, satiety, and the sodium trade-off across curing styles. All five are covered, though only the first three carry direct cited evidence; satiety is named as the weakest leg and explicitly under-evidenced for whole table olives. The sodium trade-off is the load-bearing editorial choice — the curing-style framing organises the protocol and the contraindications.

Score rationale, the close calls. Longevity at 2 (not 3): the cardiovascular evidence rides on PREDIMED and Mediterranean cohorts where table olives are a passenger, not the active arm; the polyphenol dose from typical whole-olive snacking sits at the lower edge of what trials measure. Evidence at 2 reflects this same gap — strong olive-oil literature, thin direct table-olive literature, mechanism well-mapped. Health-short-term at 1 is the hardest call; the polyphenol/LDL effect is biochemical not felt, and satiety is plausible but unproven for the whole-fruit matrix, so a 1 reads honest. Beauty-cumulative at 1 piggybacks on the Mediterranean-pattern signal; covered briefly in the evidence section so the score has a home in the body.

Dream narrative skipped. Overall score ~21 (below the 40 mandatory threshold). The honest hook for table olives is clarity and distinction — "it matters which jar you grab" — not aspiration or relief. A dream narrative would have rung false; the dek and tagline are written straight per the spec.

Excluded by choice. Olive oil's cardiovascular literature is referenced where it is load-bearing for the table-olive case but is the subject of a separate entry; PREDIMED, EUROLIVE, and EFSA's hydroxytyrosol claim all sit naturally there. Olive-leaf extract is named once in the evidence section as mechanistic backing (Susalit, Lockyer) but is not in scope — different product, much higher polyphenol density. Polyphenol bioavailability differences between the whole-fruit matrix and oil are flagged in the research dossier's knowledge-gaps but not in the article body — too inside-baseball for the reader, would clutter the protocol without changing the action.

Sodium controversy. The PURE / Mente line is named in the credibility range but kept out of the article. Bringing it in would force a digression on the J-curve that doesn't help readers in the relevant deciles (the meaningful snacking-on-Spanish-style audience is in the 3–6 g/day band, where Strazzullo / He / Mozaffarian are the relevant references). Flagged here in case a reviewer wants to revisit.

Future-link candidates. extra-virgin-olive-oil, mediterranean-diet, sodium-reduction, nuts-as-snack. Out-of-scope section gestures at the first three editorially; cross-link once the entries exist.

Separate-entry candidates. None surfaced during the writing. Olive-leaf extract may warrant its own entry given the Lockyer / Susalit BP findings, but the substance is distinct enough that it's not a narrowing of this entry.